In contrast, in carcinoma of the nasopharynx, stomach, breast, urothelium, and prostate, EMP1 reduces cell migration and invasion and increases apoptosis and caspase-9 expression (27, 31–34). This evidence concerns the gene CASP9 and nasopharyngeal carcinoma.